Professor
Sungkyunkwan University School of Medicine
Chairman, Department of Nuclear Medicine
Samsung Medical Center

Speciality Interests

Nuclear Oncology
Nuclear Neurology

Schedule

schedule of week
06 MON
17
TUE
18
WEN
19
THU
20
FRI
21
AM
PM

Medical School

Seoul National University College of Medicine

Specialty Training

Specialty Training
Fellowship   Seoul National University Hospital
Residency   Seoul National University Hospital
Internship   Seoul National University Hospital

Participation in Academic Societies
and Research

  • Member, Korean Medical Association
    Member, Korean Association of Internal Medicine
    Member and Scientific Committee, Korean Society of Nuclear Medicine
    Member, Korean Society of Biochemistry and Molecular Biology
    Member, Society of Nuclear Medicine
    Member, European Association of Nuclear Medicine
    Board of Trustee, Korean Society of Nuclear Medicine
    Board of Trustee, Korean Society of Molecular Imaging

    Editorial Board, Open Journal of Medical Imaging
    Editorial Board, Open Journal of Nuclear Medicine
    Editorial Board, Journal of Korean Medical Science
    Editorial Board, Nuclear Medicine and Molecular Imaging

Thesis

SCI REP-UK 2021 10.1038/s41598-021-88815-2

Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation

Park1, YJ; Hyun, SH; Moon, SH; Lee, KH; Min, BH; Lee, JH; Kim, WS; Kim, SJ; Choi, JY

SCI REP-UK 2021 10.1038/s41598-021-85332-0

Metabolic activity of extranodal NK/T cell lymphoma on F-18-FDG PET/CT according to immune subtyping

Lim1, CH; Yoon, SE; Kim, SJ; Cho, J; Ko, YH; Lee, KH; Kim, WS

SCI REP-UK 2021 10.1038/s41598-021-83496-3

Zr-89 anti-CD44 immuno-PET monitors CD44 expression on splenic myeloid cells and HT29 colon cancer cells

Park1, JW; Jung, KH; Lee, JH; Moon, SH; Cho, YS; Lee, KH

CANCERS 2021 10.3390/cancers13040712

Prognostic Significance of Metabolic Parameters by F-18-FDG PET/CT in Thymic Epithelial Tumors

Lee1, J; Cho, YS; Kim, J; Shim, YM; Lee, KH; Choi, JY

ONCOL LETT 2020 10.3892/ol.2020.12237

Genipin enhances the antitumor effect of elesclomol in A549 lung cancer cells by blocking uncoupling protein-2 and stimulating reactive oxygen species production

Lee1, JH; Cho, YS; Jung, KH; Park, JW; Lee, KH

CLOSE

Patients' Rights and Responsibilities

Patients' Rights

1. Right to receive medical care

Patients have the right to receive proper care in a safe setting without discrimination nor should their right to care be violated regardless of their gender, age, religion, social status, nationality, language, race, or physical/mental/financial status. Medical teams shall not refuse to provide care without justifiable reason.

2. Right to be informed and to make an autonomous decision

Patients have the right to obtain full and complete information from their medical team, to ask questions, and to determine their agreement or refusal concerning: diagnosis, treatment (purpose, plans and methods), outcomes of care (including unanticipated outcomes), discharge plan, participation in medical research studies, organ transplantation/donation, etc. Within ethical boundaries, patients may discontinue or refuse treatment, request that the medical team explain and suggest alternative treatments, and reserve the right to make their own decisions.

3. Right to confidentiality

Patients' rights to confidentiality regarding their physical/health status and privacy will not be violated. Patients can expect that all medical records/reports and their personal privacy will be kept confidential unless the patient has given consent or disclosure is permitted by law. To ensure their privacy, patients may be informed that Individuals not directly involved in their care may not be present and that the number of guardians accompanying patients to consultation rooms may be limited.

4. Right to request consultation and mediation

In the event of a medical dispute, patients may request consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency).

5. Right to have values and beliefs respected

Patients will not be discriminated against because of their culture, religious values, or beliefs, and their rights will not be violated.

6. Right to receive care in a safe setting

Patients have the right to receive hospital-provided care where the patient’s medical information is protected and patient safety can be assured. In addition, patients have the right to be protected from possible dangers that can occur in a hospital and to have stability of mind and body.

Patients' Responsibilities

1. Responsibility to trust and respect the medical team

Patients must accurately inform the medical team of their health condition and must trust and respect the medical team's treatment plan. Patients may be responsible for consequences that result from not following instructions.

2. Responsibility to not use dishonest methods for medical treatment

Patients must reveal their identity before receiving any medical care and must not use false or dishonest methods, such as seeking medical care under disguised ownership.

3. Responsibility to abide by all hospital regulations

Patients are expected to treat all hospital staff and other patients with courtesy and respect; to abide by all hospital rules; and to earnestly fulfill their financial obligation to the hospital. Also, patients and their family members are expected to participate in all safety regulations.